FDA Authorizes Zyn to Market Its Nicotine Pouches as Safer Alternatives to Cigarettes
Zyn's nicotine pouch marketing is approved by the FDA, claiming lower risks compared to cigarettes, prompting concern am...
Found 513 results
Zyn's nicotine pouch marketing is approved by the FDA, claiming lower risks compared to cigarettes, prompting concern am...
Anthropic launches Claude Science to aid pharmaceutical research, while Trump's drug pricing plans face hurdles with mid...
A team has created potential synthetic cells, sparking debate over their life-like properties and implications for biolo...
Multiplet, an engaging daily puzzle game, redefines chemistry learning with fun challenges that rival popular word games...
A recent study highlights that older adults with obesity are achieving better cardiovascular health metrics, potentially...
Jails face challenges in managing severe withdrawal symptoms from fentanyl laced with medetomidine, highlighting critica...
While Richard Preston's "The Hot Zone" drew many to infectious diseases, it created lasting misconceptions about Ebola t...
Joseph Fraumeni Jr. dedicated his life to cancer research, significantly transforming the understanding of hereditary ca...
A patient with pulmonary hypertension received Eli Lilly's unapproved obesity drug under compassionate use, sparking int...
The European Commission is probing Sanofi for allegedly undermining a competitor's flu vaccine in its promotional activi...
New advancements in embryo editing highlight safety and efficacy but raise old ethical questions, making this a key topi...
The 988 LGBTQ+ crisis hotline is set to relaunch, but concerns arise over the exclusion of The Trevor Project, pivotal i...
At BIO 2026, the mood was markedly more positive compared to previous events, showcasing a renewed energy in the biotech...
Recent advancements in human embryo editing technology raise significant ethical concerns that require open dialogue amo...
Public radio proved essential in recruiting over 20,000 participants for a groundbreaking study on the effects of walkin...
Ollin Biosciences raises $330 million in Series B funding for a pivotal Phase 3 trial targeting serious eye diseases aff...
Regenxbio plans to seek accelerated approval for its Duchenne muscular dystrophy gene therapy, navigating evolving FDA p...
Highlights from the BIO conference include Regenxbio's promising gene therapy announcement and Ollin Biosciences' impres...
A new study leverages AI to identify at-risk individuals for sudden cardiac arrest, revealing the role of cardiac fibros...
A recent BIOtech event in San Diego highlights significant breakthroughs in AI and unexpected pharmaceutical development...